Veraxa Biotech Holding AG (VRXA) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Veraxa Biotech Holding AG (VRXA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $299.8M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 0.25 to the broader market. Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp. Led by Christoph Antz, public since 2026-06-09.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for VRXA as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →